Rio Grande Neurosciences
San Francisco, US · Founded 2011 · Delaware corporation
Founders & leadership
BG
Blake GurfeinChief Science Officer
SH
Sean HagbergChief Strategist
SG
Steven GlucksternNamed on SEC filing
Board
LJ
L. John WilkersonBoard director
SJ
Stephen JuelsgaardBoard director
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 5 rounds · 2014–2016
▶$828.4KraisedFeb 2016 · 9 investors · Other Health CareRule 506(b)
▶$828.4KraisedFeb 2016 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven M. GlucksternExecutive Officer, Director
- Blake GurfeinExecutive Officer
- Sean HagbergExecutive Officer
- L. John WilkersonDirector
- Stephen JuelsgaardDirector
- Offering amount
- $969.1K
- Amount sold
- $828.4K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$3.7MraisedJan 2016 · 1 investors · Other Health CareRule 506(b)
▶$3.7MraisedJan 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Blake GurfeinExecutive Officer
- Steven M. GlucksternExecutive Officer, Director
- L. John WilkersonDirector
- Stephen JuelsgaardDirector
- Sean HagbergExecutive Officer
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$2MraisedOct 2015 · 11 investors · Other Health CareRule 506(b)
▶$2MraisedOct 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen JuelsgaardDirector
- Sean HagbergExecutive Officer
- John L WilkersonDirector
- Blake GurfeinExecutive Officer
- Steven GlucksternExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$1.1MraisedMay 2015 · 11 investors · Other Health CareRule 506(b)
▶$1.1MraisedMay 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven GlucksternExecutive Officer, Director
- Blake GurfeinExecutive Officer
- Stephen JuelsgaardDirector
- L. John WilkersonDirector
- Sean HagbergExecutive Officer
- Offering amount
- $8M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- Sales commissions
- $400K
- Placement agents
- Middlebury Securities, LLC
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$1.3MraisedAug 2014 · 34 investors · Other Health CareRule 506(b)
▶$1.3MraisedAug 2014 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen JuelsgaardDirector
- Steven GlucksternExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Rio Grande Neurosciences raised?
- Rio Grande Neurosciences has disclosed $8.9M raised across 5 rounds.
- Where is Rio Grande Neurosciences headquartered?
- Rio Grande Neurosciences is headquartered in San Francisco, US.